Short answer
SelectQuote, Inc. (SLQT) filed its Q3 2026 10-Q quarterly report on Nov 4, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $280M (down 14.8% year over year) with net income of −$20M.
Q3 2026 key financials · XBRL
- Revenue
- $280M
- −14.8% YoY
- Net income
- −$20M
- +33.3% YoY
- Operating margin
- -10.2%
- EPS (diluted)
- −$0.21
- +19.2% YoY
Source: XBRL data from the SelectQuote, Inc. (SLQT) Q3 2026 10-Q on SEC EDGAR. USD.
SelectQuote, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $280.0M, down 15% YoY from $328.8M, including pharmacy revenue down 16% to $184.0M
- Net loss $20.3M vs $30.5M; operating margin (10%) vs (12%) YoY, net margin (7%) vs (9%)
- Healthcare Services largest segment at $186.3M revenue, down 16%; Senior weakest Adjusted EBITDA at $(12.3)M
- Cash, equivalents and restricted cash $14.3M vs $21.7M; operating cash use $17.2M, investing cash use $3.6M
- Management expects existing cash, revolver availability and operating cash to fund working capital, investments and debt service; SelectRx members down 7% with profitability per member up 60%
Risk Factors
- No material changes to Annual Report risk factors disclosed this quarter
- Carried-forward business risk: known and unknown risks could materially harm operations
- Carried-forward financial risk: identified risks could materially impair financial condition
- Carried-forward investor risk: risk realization could adversely affect securities value
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SelectQuote, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.